1 / 8

REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH

REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH. FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Senior Associate Commissioner for Science. FDA REGULATES. 20 percent of the consumer purchases $50 billion of medical R&D 8 million import shipments/year

adin
Télécharger la présentation

REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Senior Associate Commissioner for Science Nanotechnology - USDA - 18 Nov 2002

  2. FDA REGULATES • 20 percent of the consumer purchases • $50 billion of medical R&D • 8 million import shipments/year • Food, drugs, biologicals, devices, cosmetics, blood • Counter terrorism products Nanotechnology - USDA - 18 Nov 2002

  3. FDA’S PUBLIC HEALTH MISSION • Safety • Efficacy • Good Manufacturing controls • Risk analysis • Be a force in counter-terrorism Nanotechnology - USDA - 18 Nov 2002

  4. FDA ORGANIZATION • Center for Biologics Evaluation and Research • Center Drug Evaluation and Research • Center for Devices and Radiological Health • Center for Food Safety and Applied Nutrition • Center for Veterinary Medicine • Office of Regional Operations • National Center for Toxicological Research Nanotechnology - USDA - 18 Nov 2002

  5. PUBLIC HEALTH IMPLICATIONS FOR NANOTECHNOLOGY • New materials and manufacturing processes • All FDA regulated areas are likely affected • drugs, medical devices, biologicals, food • The science is new to the Agency • Risk management is our job • Education of the Public will define its acceptance Nanotechnology - USDA - 18 Nov 2002

  6. NATIONAL NANOTECHNOLOGY INITIATIVE • Examples of fundamental research that will be regulated by FDA • Biological assembly of nanostructures • Using DNA molecules to construct nanoscale devices • Artificial genetic system • Modeling and simulation of biological ion channels to cure diseases • Nanoscale film serves as molecular filter Nanotechnology - USDA - 18 Nov 2002

  7. NANOTECHNOLOGY AND COMMERCIALIZATION OF PUBLIC HEALTH PRODUCTS • Education & training of FDA • Education of the Public – Developing the public perception • Education and training of industry sectors unfamiliar with FDA • Demonstrate the safety of products • Demonstrate the efficacy of products • Establishment of standards of manufacturing, performance, and approval • Risk analysis and management Nanotechnology - USDA - 18 Nov 2002

  8. CHALLENGES!! • New technology – Unknown risks • Education – A bad job here can minimize the utility • Stakeholder involvement • Early involvement of all parties • Risk communication • FDA guidance development – Help us. Nanotechnology - USDA - 18 Nov 2002

More Related